Which statement is a key strength of randomized controlled trials?

Which statement is a key strength of randomized controlled trials?

• A. Strong internal validity due to randomization
• B. Quick and inexpensive
• C. Real-world generalizability
• D. No ethical constraints

Answer: (A)

The main strength of randomized controlled trials is their high internal validity, achieved by random assignment of participants to intervention or control groups. Randomization makes the groups comparable at the start and distributes both known and unknown confounding factors roughly equally, so differences in outcomes are more likely due to the intervention itself. This supports causal conclusions about effectiveness. When allocation is concealed and blinding is used, biases in how participants are treated or how outcomes are measured are further reduced, reinforcing the trustworthiness of the observed effect. In contrast, statements about being quick and inexpensive, broad real-world generalizability, or lacking ethical constraints don’t fit the design’s typical strengths and drawbacks; trials often require substantial time and resources, may have limited generalizability due to strict protocols, and ethical considerations are central to their conduct.

The main strength of randomized controlled trials is their high internal validity, achieved by random assignment of participants to intervention or control groups. Randomization makes the groups comparable at the start and distributes both known and unknown confounding factors roughly equally, so differences in outcomes are more likely due to the intervention itself. This supports causal conclusions about effectiveness. When allocation is concealed and blinding is used, biases in how participants are treated or how outcomes are measured are further reduced, reinforcing the trustworthiness of the observed effect. In contrast, statements about being quick and inexpensive, broad real-world generalizability, or lacking ethical constraints don’t fit the design’s typical strengths and drawbacks; trials often require substantial time and resources, may have limited generalizability due to strict protocols, and ethical considerations are central to their conduct.